Literature DB >> 24127202

Challenges in diagnosing Muckle-Wells syndrome: identifying two distinct phenotypes.

Jasmin B Kuemmerle-Deschner1, Samuel Dembi Samba, Pascal N Tyrrell, Isabelle Koné-Paut, Isabelle Marie, Norbert Deschner, Susanne M Benseler.   

Abstract

OBJECTIVE: The diagnosis of Muckle-Wells syndrome (MWS) remains challenging due to the clinical heterogeneity and lack of diagnostic criteria. The aims of this study were to describe key elements of the diagnostic evaluation process in MWS and compare identified variables between patients diagnosed in childhood and adulthood.
METHODS: A cohort study of consecutive patients with a clinical and genetic diagnosis of MWS was conducted at 2 reference centers for autoinflammatory diseases. Demographic information, clinical presentation, access to care, and preclinical evaluation variables were captured. Presenting symptoms were compared between groups of patients diagnosed in childhood and adulthood. Prediction analysis explored variables associated with late diagnosis. Correspondence analysis identified clinical phenotypes.
RESULTS: A total of 34 MWS patients were included (16 males, 18 females) and median age at diagnosis was 31.5 years (range 0.5-75 years). Patients diagnosed during childhood reported musculoskeletal symptoms (62%), rash (62%), fever (54%), and abdominal pain (31%). Those diagnosed as adults described musculoskeletal symptoms (86%), rash (67%), hearing loss (52%), and fatigue (29%). Hearing loss was associated with late diagnosis, while access-to-care variables were not predictive. Correspondence analysis identified distinct clinical phenotypes as follows: an "inflammatory phenotype" (most commonly seen in patients diagnosed in childhood and characterized by relapsing fever and abdominal pain), an intermediate phenotype, and an "organ-disease" phenotype in patients diagnosed during adulthood and characterized by fatigue and hearing loss.
CONCLUSION: Distinct clinical phenotypes were identified in patients with MWS. These are closely related to age at diagnosis. The presence of these phenotypes has to be considered when developing diagnostic criteria for MWS.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2014        PMID: 24127202     DOI: 10.1002/acr.22206

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  7 in total

1.  [Pain and epilepsy : A clinical, neuroanatomical and pathophysiological review].

Authors:  P Martin
Journal:  Schmerz       Date:  2018-08       Impact factor: 1.107

Review 2.  [Autoinflammatory syndromes : Practical approach to diagnostics and therapy].

Authors:  J B Kümmerle-Deschner
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

3.  Magnetic resonance imaging findings in a patient with cryopyrin-associated periodic syndrome: A rare hereditary multi-system inflammatory disorder.

Authors:  Jessica Behringer; Maura Ryan; Michael Miller; Alok Jaju
Journal:  Neuroradiol J       Date:  2019-07-24

4.  Muckle-Wells syndrome in Chinese patients: a single center case series.

Authors:  Di Wu; Min Shen
Journal:  Clin Rheumatol       Date:  2016-12-27       Impact factor: 2.980

5.  The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist.

Authors:  Micol Romano; Z Serap Arici; David Piskin; Sara Alehashemi; Daniel Aletaha; Karyl Barron; Susanne Benseler; Roberta A Berard; Lori Broderick; Fatma Dedeoglu; Michelle Diebold; Karen Durrant; Polly Ferguson; Dirk Foell; Jonathan S Hausmann; Olcay Y Jones; Daniel Kastner; Helen J Lachmann; Ronald M Laxer; Dorelia Rivera; Nicola Ruperto; Anna Simon; Marinka Twilt; Joost Frenkel; Hal M Hoffman; Adriana A de Jesus; Jasmin B Kuemmerle-Deschner; Seza Ozen; Marco Gattorno; Raphaela Goldbach-Mansky; Erkan Demirkaya
Journal:  Arthritis Rheumatol       Date:  2022-05-27       Impact factor: 15.483

Review 6.  IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives.

Authors:  Hana Malcova; Zuzana Strizova; Tomas Milota; Ilja Striz; Anna Sediva; Dita Cebecauerova; Rudolf Horvath
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

Review 7.  Monogenic autoinflammatory diseases in adults - a challenge to rheumatologic practice at the onset of the Polish national programme of interleukin 1 inhibitor treatment.

Authors:  Marcin Milchert; Joanna Makowska; Olga Brzezińska; Marek Brzosko; Ewa Więsik-Szewczyk
Journal:  Reumatologia       Date:  2019-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.